Clinical Trial Update: A Study to Compare the Frequency of Constipation Symptoms With Tapentadol Immediate Release (IR) Treatment Versus Oxycodone IR Treatment in Patients With End-stage Joint Disease [Phase 3]

View source ↗

Summary

Phase 3 study comparing the frequency of constipation symptoms between tapentadol immediate-release and oxycodone immediate-release in patients with end-stage j…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Osteoarthritis

Drugs mentioned

• Nucynta IR (tapentadol)
• Oxycodone IR (oxycodone)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Joint Diseases, Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2012-02-13